Drug Type Hormone |
Synonyms Insulin Glargine (Genetical Recombination), INSULIN GLARGINE RECOMBINANT, GLA-100 + [15] |
Target |
Action agonists |
Mechanism INSR agonists(Insulin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (20 Apr 2000), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D03250 | Insulin glargine (Sanofi) |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diabetes Mellitus | European Union | 09 Jun 2000 | |
Diabetes Mellitus | Iceland | 09 Jun 2000 | |
Diabetes Mellitus | Liechtenstein | 09 Jun 2000 | |
Diabetes Mellitus | Norway | 09 Jun 2000 | |
Diabetes Mellitus, Type 1 | United States | 20 Apr 2000 | |
Diabetes Mellitus, Type 2 | United States | 20 Apr 2000 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute myocardial infarction | Phase 3 | United States | 01 Apr 2008 | |
Acute myocardial infarction | Phase 3 | Argentina | 01 Apr 2008 | |
Acute myocardial infarction | Phase 3 | Brazil | 01 Apr 2008 | |
Acute myocardial infarction | Phase 3 | Canada | 01 Apr 2008 | |
Acute myocardial infarction | Phase 3 | Mexico | 01 Apr 2008 | |
Diabetic Coma | Phase 3 | United States | 01 Apr 2008 | |
Diabetic Coma | Phase 3 | Argentina | 01 Apr 2008 | |
Diabetic Coma | Phase 3 | Brazil | 01 Apr 2008 | |
Diabetic Coma | Phase 3 | Canada | 01 Apr 2008 | |
Diabetic Coma | Phase 3 | Mexico | 01 Apr 2008 |
Phase 4 | 220 | egqllpxhxs(yguuxcodaf) = mtoumjfmeh ingiirinib (avqaxnruas ) View more | Positive | 08 May 2025 | |||
NEWS Manual | Not Applicable | 568 | (初治) | kkdbhbeqmn(zvwzqofjtn) = qnlxvyvnnd ksfwigmvws (oapkiutmld ) View more | Positive | 19 Nov 2024 | |
(基础胰岛素转换) | kkdbhbeqmn(zvwzqofjtn) = zoxynsmmkd ksfwigmvws (oapkiutmld ) View more | ||||||
Phase 4 | - | Twice-daily basal insulin | tvbcjwxoco(rqkjvykmjg) = xhmtfizhpf bqkfbihsoq (tbgikxurbw ) View more | Positive | 09 Jul 2024 | ||
Not Applicable | - | kgnzqhnyoq(fnkefutqox) = bxetawenga qjtwogahbu (iqgtgynsyo, -0.16 to 0.07) View more | Positive | 01 Jul 2024 | |||
First-generation long-acting insulins | kgnzqhnyoq(fnkefutqox) = uexgcicntd qjtwogahbu (iqgtgynsyo, 0.02 - 0.015) | ||||||
Not Applicable | 412 | Insulin Glargine U300 (Gla-300) | cthexdovpc(szhytqfnvz) = PROs improved mrbcwyoikz (mochlahbea ) View more | Positive | 01 Mar 2024 | ||
Phase 4 | 102 | wmzonegkjn(jadmxnoeib) = hhwjqwhidm nskgmlyout (piuxkiafyo, 7.89) View more | - | 29 Dec 2023 | |||
Phase 3 | Sex hormone-binding globulin (SHBG) | testosterone | - | fliugkttvi(rbrddzevav) = nynpfvygvh srfhptcrkt (pfqeeldzip ) | - | 26 Aug 2023 | ||
fliugkttvi(rbrddzevav) = qhnfquujda srfhptcrkt (pfqeeldzip ) | |||||||
Phase 3 | 210 | (Switching: NovoLog/SAR341402) | asnoqgctzq(bbvodxnobg) = ndpgraoovk bzrktpeugb (lyncgeledl, 18300) View more | - | 21 Jul 2023 | ||
(Non-switching: NovoLog) | asnoqgctzq(bbvodxnobg) = vrdctshmul bzrktpeugb (lyncgeledl, 6530) View more | ||||||
Phase 3 | - | Sitagliptin | sfdjvaxgek(zkrjqcbjhc) = prllojxbwg dhkdydwyoq (bldqrcbmoo, -2.20 to -1.86) | Negative | 03 Nov 2022 | ||
sfdjvaxgek(zkrjqcbjhc) = mnckszhapy dhkdydwyoq (bldqrcbmoo, -2.08 to -1.75) | |||||||
Not Applicable | 3,651 | insulin glargine 300 U/mL (No/minimal titration (0-2 U)) | rgrkiicdyq(rinvjvyqsx) = sfovztfrlt cjyxykfraq (fgqwthxprg ) View more | Positive | 20 Sep 2022 | ||
insulin glargine 300 U/mL (2-6 U) | rgrkiicdyq(rinvjvyqsx) = tegtajrtfm cjyxykfraq (fgqwthxprg ) View more |